Access to measles vaccines through the National Immunisation Program
This media release is to reassure the Australian public that access to measles vaccines through the National Immunisation Program is available.
Australia’s Department of Health has reassured the Australian public there is a sufficient supply of measles vaccine to meet ongoing demand and that supplies under the National Immunisation Program are secured.
While one pharmaceutical supplier (GlaxoSmithKline) has advised of a shortage of MMR and MMRV vaccines, the department has confirmed vaccines remain available through another supplier (Seqirus Australia Pty Ltd).
The department also confirmed the National Immunisation Program – which provides free essential vaccines for eligible infants, children, adolescents and adults – is not impacted by this situation. The department has worked closely with suppliers to assure this supply.
Measles vaccines are also available in the private market although the supply is being carefully managed by Seqirus.
Immunisation for measles and for many other diseases is the safest and most effective way of protecting against disease. Immunisation not only protects individuals and their families, but also supports the whole community by helping to control vaccine preventable diseases.